Uracil

Uracil

SCHEMBL479740

CC(=O)O.O=c1cc[nH]c(=O)[nH]1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Uracil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 2/20 0.74
▸ MMP2 P08253 2/20 0.46
▸ TP53 P04637 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP1A2 P05177 1/20 0.33
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ TYMP P19971 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ NOTUM Q6P988 1/20 0.32
▸ NAPRT Q6XQN6 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ ATAD2 Q6PL18 1/20 0.31
▸ MMP1 P03956 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP12 P39900 1/20 0.31
▸ FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uracil SCHEMBL4652740 1.00 CRBN (0.74) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL2895220 0.98 CRBN (0.71) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL9429688 0.89 CRBN (0.77) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL25208560 0.88 CRBN (0.63) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL2895224 0.88 CRBN (0.68) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL11607890 0.86 — —
Uracil SCHEMBL8235 0.86 — —
Uracil SCHEMBL3798527 0.86 CRBN (1.00) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL5089507 0.86 — —
Uracil SCHEMBL21385227 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101104608-B Solanesol derivative, preparation and application thereof UNIV HENAN 2011-05-04 — — CN claimed
CN-101104608-A Solanesol derivative, preparation and application thereof UNIV HENAN (CN) 2008-01-16 — — CN claimed
US-20250281627-A1 CANCER-TARGETING PEPTIDE, PRODRUG NANOPARTICLES COMPRISING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR CANCER PREVENTION OR TREATMENT NOXPHARM CO., LTD. (KR) 2025-09-11 — — US disclosed
WO-2025038588-A1 NANOPARTICLES, THEIR PREPARATION AND USE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2025-02-20 — — WO disclosed
WO-2024111844-A1 CANCER-TARGETING PEPTIDE, PRODRUG NANOPARTICLES COMPRISING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR CANCER PREVENTION OR TREATMENT 이화여자대학교 산학협력단 2024-05-30 — — WO disclosed
CN-113845483-B Pink back pteridonic acid and 5-fluorouracil hybrid, preparation method and application thereof 安徽工业大学 2023-08-22 — — CN disclosed
CN-110256361-B Bishydrazide compound containing phenylpyrimidinone structural fragment and preparation method thereof 湖南人文科技学院 2023-06-16 — — CN disclosed
CN-111171041-B 20-substituted camptothecin derivative and preparation method and application thereof 中国海洋大学 2021-07-27 — — CN disclosed
US-10849733-B2 Glucose-responsive artificial muscle and manufacturing method therefor INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) 2020-12-01 — — US disclosed
CN-111171041-A 20-substituted camptothecin derivative and preparation method and application thereof 中国海洋大学 2020-05-19 — — CN disclosed
CN-110256361-A A kind of bishydrazide compounds and preparation method thereof of the structure fragment of ketone containing phenyl pyrimidine 湖南人文科技学院 2019-09-20 — — CN disclosed
WO-2007104979-A1 VIRUS-LIKE PARTICLES OF RIFT VALLEY FEVER VIRUS LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE (GB) 2007-09-20 — — WO disclosed
US-20040093638-A1 Method for promoting fatty acid synthesis in a plant NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) 2004-05-13 — — US disclosed
EP-1241262-A2 A method for promoting fatty acid synthesis in a plant Nara Institute of Science and Technology (JP) 2002-09-18 — — EP disclosed
WO-1999014216-A1 SUBSTITUTED 3(-1,2-BENZISOTHIAZOL OR ISOXAZOL-5 YL)-SUBSTITUTED PYRIMIDINE AS HERBICIDES AMERICAN CYANAMID COMPANY (US) 1999-03-25 — — WO disclosed
EP-0540707-B1 Di(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION ACAD OF SCIENCE CZECH REPUBLIC (CS) 1995-11-15 — — EP disclosed
US-5352786-A Di(2-propyl)esters of 1-fluoro-2-phosphonomethoxy-3-P-to-luenesulfonyloxypropanes, their producing and utilization INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) 1994-10-04 — — US disclosed
EP-0540707-A1 Di(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION. CESKOSLOVENSKA AKADEMIE VED (CS) 1993-05-12 — — EP disclosed
WO-1992020692-A1 DI(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION GILEAD SCIENCES, INC. (US) 1992-11-26 — — WO disclosed
WO-1992020691-A1 Di(2-PROPYL)ESTERS OF 1-FLUORO-2-PHOSPHONOMETHOXY-3-P-TOLUENESULFONYLOXYPROPANES, THEIR PRODUCING AND UTILIZATION C^¿ESKOSLOVENSKÁ AKADEMIE VE^¿D (CS) 1992-11-26 — — WO disclosed
Send feedback